Global Literature Review: Ensuring Safety through Robust Processes

Learn how our end-to-end GLR process enhances patient safety and supports regulatory compliance worldwide.
GLR cover image - Ensuring Safety through Robust Processes 2025

In pharmacovigilance, timely identification of safety signals is essential to protecting patients – which is why our Global Literature Review (GLR) process provides a systematic and reliable way to capture, analyze, and document safety data from trusted scientific sources like Embase and PubMed.

With tailored search strategies, advanced screening, and clear reporting practices, we help pharmaceutical companies ensure compliance while strengthening their safety surveillance.

Whether as part of a global pharmacovigilance project or a standalone service, our GLR process delivers precision, adaptability, and excellence you can trust.

Download our bulletin below to learn more:

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information